The Nutrition cluster is made up of DSM Nutritional Products and DSM Food Specialties. DSM Nutritional Products is one of the world’s leading producers of essential nutrients such as vitamins, carotenoids, nutritional lipids and other ingredients to the feed, food, pharmaceutical and personal care industries. DSM Food Specialties’ food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids and other specialty ingredients are found in the world’s favorite dairy, baking, beverage and savory brands.
The Materials cluster is made up of DSM Engineering Plastics, DSM Dyneema and DSM Resins & Functional Materials. DSM Engineering Plastics is a global player in specialty plastics. These materials are used in components for the electrical and electronics, automotive, flexible food packaging and consumer goods industries. DSM Dyneema is the inventor, manufacturer and marketer of Dyneema?, the world’s strongest fiber?. DSM Resins & Functional Materials is a global producer of innovative, sustainable resins solutions for paints and industrial and optical fiber coatings.
Besides supporting innovation in our core businesses and venturing activities, the DSM Innovation Center also aims to develop its Emerging Business Areas (EBAs). They comprise DSM Biomedical, focused on innovative materials for medical devices; DSM Bio-based Products & Services, which focuses on clean energy from crop residues as well as bio-chemicals with enzymes and yeasts for biomass conversion; and DSM Advanced Solar, which offers yield-boosting solutions for solar energy.
Beginning in 2011 DSM established a number of partnerships for its Pharma and Bulk Chemicals activities in order to streamline and simplify its core portfolio in Nutrition and Materials. These partnerships were created with a view to ultimately exiting these businesses and maximizing their value.
DSM has subsequently divested its interests in Patheon (pharmaceutical contract development and manufacturing) in August 2017 and both DSM Sinochem Pharmaceuticals (generic anti-infective molecules) and Fibrant (caprolactam) in October 2018.
DSM currently retains a 35% interest in its ChemicaInvest joint venture with CVC Capital Partners. This now comprises two business units (following the sale of Fibrant), Aliancys (composite resins) and AnQore (acrylonitrile).